CD4 and neoplasm: As a result, 24 h after intratumoral injection, mice that received AAA-CD4+ T-cell therapy had significantly more host-type NK cells in the tumor than mice that received auto-CD4+ T cells and PBS-treated control mice (Supplementary Fig. S8a).